sodium channel associated protein 2 |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
sodium channel, voltage-gated, type III, beta |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
carbonic anhydrase XI |
CHLORTHALIDONE |
Carbonic Anhydrase |
90% |
.677uM |
NoneNone |
View
|
carbonic anhydrase IX |
CHLORTHALIDONE |
Carbonic Anhydrase |
90% |
.677uM |
NoneNone |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
TERCONAZOLE |
Imidazoline I2, Central |
90% |
2.226uM |
1.484uM |
View
|
adenosine A1 receptor |
SILDENAFIL |
Adenosine A1 |
90% |
1.493uM |
.871uM |
View
|
progesterone receptor |
STANOLONE |
Progesterone |
90% |
1.247uM |
.163uM |
View
|
progesterone receptor |
STANOLONE |
Progesterone |
90% |
1.247uM |
.163uM |
View
|
adrenergic receptor, alpha 2b |
PRAZOSIN |
Adrenergic alpha2C |
90% |
.647uM |
.094uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
PRAZOSIN |
Adrenergic alpha2C |
90% |
.647uM |
.094uM |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
METERGOLINE |
Serotonin Transporter |
90% |
.59uM |
.313uM |
View
|
prostaglandin-endoperoxide synthase 1 |
6-METHOXY-2-NAPHTHYLACETIC ACID |
Cyclooxygenase COX-1 |
90% |
4.113uM |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
6-METHOXY-2-NAPHTHYLACETIC ACID |
Cyclooxygenase COX-1 |
90% |
4.113uM |
NoneNone |
View
|
cholinergic receptor, muscarinic 4 |
PENTAMIDINE |
Muscarinic M4 |
90% |
1.58uM |
.22uM |
View
|
adrenergic receptor, alpha 2a |
EPINEPHRINE |
Adrenergic alpha2A |
90% |
.737uM |
.276uM |
View
|
adrenergic receptor, alpha 2b |
GUANABENZ |
Adrenergic alpha2C |
90% |
1.106uM |
.161uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
GUANABENZ |
Adrenergic alpha2C |
90% |
1.106uM |
.161uM |
View
|
adrenergic receptor, alpha 1b |
GUANABENZ |
Adrenergic alpha1B |
90% |
1.365uM |
.755uM |
View
|
adrenergic receptor, alpha 1d (Non-specific probe) |
GUANABENZ |
Adrenergic alpha1D |
90% |
.472uM |
.232uM |
View
|
mitogen activated protein kinase 14 |
1-(2-METHYLBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Protein Serine/Threonine Kinase, p38alpha |
90% |
.329uM |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
1-(2-METHYLBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Protein Serine/Threonine Kinase, p38alpha |
90% |
.329uM |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
ECONAZOLE |
CYP450-2C9 Inhibition |
90% |
.2uM |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
ECONAZOLE |
CYP450-2C9 Inhibition |
90% |
.2uM |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
adrenergic receptor, beta 1 |
ECONAZOLE |
Adrenergic beta1 |
90% |
12.821uM |
7.404uM |
View
|
adrenergic, beta-1-, receptor |
ECONAZOLE |
Adrenergic beta1 |
90% |
12.821uM |
7.404uM |
View
|
monoamine oxidase A |
BENZO[A]PYRENE |
Monoamine Oxidase MAOA |
90% |
5.972uM |
NoneNone |
View
|
monoamine oxidase A |
BENZO[A]PYRENE |
Monoamine Oxidase MAOA |
90% |
5.972uM |
NoneNone |
View
|
adrenergic receptor, alpha 2a |
CIGLITAZONE |
Adrenergic alpha2A |
90% |
16.551uM |
6.207uM |
View
|
cholinergic receptor, muscarinic 1 |
SULCONAZOLE |
Muscarinic M1 |
90% |
3.675uM |
.885uM |
View
|
Protein-tyrosine kinase, Fyn |
DIETHYLSTILBESTROL |
Protein Tyrosine Kinase, Fyn |
90% |
14.233uM |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
DIETHYLSTILBESTROL |
Adrenergic alpha2C |
90% |
15.151uM |
2.201uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
DIETHYLSTILBESTROL |
Adrenergic alpha2C |
90% |
15.151uM |
2.201uM |
View
|
mu-opioid receptor MOR |
DIETHYLSTILBESTROL |
Opiate mu |
90% |
5.778uM |
2.345uM |
View
|
dopamine receptor D3 |
AMIFOSTINE |
Dopamine D3 |
90% |
1.929uM |
.655uM |
View
|
sodium channel, voltage-gated, type I, alpha |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
amiloride-sensitive cation channel 5, intestinal |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
sodium channel, voltage-gated, type III, beta |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
sodium channel, voltage-gated, type I, beta |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
sodium channel, voltage-gated, type II, beta |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
sodium channel, nonvoltage-gated 1 alpha |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
aldo-keto reductase family 1, member B4 (aldose reductase) |
TANNIC ACID |
Aldose Reductase |
90% |
.346uM |
NoneNone |
View
|
aldo-keto reductase family 1, member B1 (aldose reductase) |
TANNIC ACID |
Aldose Reductase |
90% |
.346uM |
NoneNone |
View
|
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
TANNIC ACID |
Aldose Reductase |
90% |
.346uM |
NoneNone |
View
|
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
TANNIC ACID |
Aldose Reductase |
90% |
.346uM |
NoneNone |
View
|
adrenergic receptor, alpha 1d (Non-specific probe) |
AMOXAPINE |
Adrenergic alpha1D |
90% |
.306uM |
.15uM |
View
|
adrenergic receptor, beta 1 |
CLOTRIMAZOLE |
Adrenergic beta1 |
90% |
11.279uM |
6.513uM |
View
|
adrenergic, beta-1-, receptor |
CLOTRIMAZOLE |
Adrenergic beta1 |
90% |
11.279uM |
6.513uM |
View
|
progesterone receptor |
CLOTRIMAZOLE |
Progesterone |
90% |
8.774uM |
1.144uM |
View
|
progesterone receptor |
CLOTRIMAZOLE |
Progesterone |
90% |
8.774uM |
1.144uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
cholinergic receptor, muscarinic 5 |
AMIODARONE |
Muscarinic M5 |
90% |
1.499uM |
1.077uM |
View
|
dopamine receptor D1A |
AMIODARONE |
Dopamine D1 |
90% |
9.142uM |
4.571uM |
View
|
dopamine receptor 2 |
AMIODARONE |
Dopamine D2L |
90% |
19.952uM |
6.651uM |
View
|
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
CHLORPROMAZINE |
Dopamine Transporter |
90% |
2.643uM |
2.1uM |
View
|
carbonic anhydrase 5a, mitochondrial |
CHLORTHALIDONE |
Carbonic Anhydrase |
90% |
.677uM |
NoneNone |
View
|
carbonic anhydrase 3 |
CHLORTHALIDONE |
Carbonic Anhydrase |
90% |
.677uM |
NoneNone |
View
|
carbonic anhydrase 2 |
CHLORTHALIDONE |
Carbonic Anhydrase |
90% |
.677uM |
NoneNone |
View
|
carbonic anhydrase 4 |
CHLORTHALIDONE |
Carbonic Anhydrase |
90% |
.677uM |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
PROPAFENONE |
Calcium Channel Type L, Phenylalkylamine |
91% |
1.744uM |
1.695uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
PROPAFENONE |
Calcium Channel Type L, Phenylalkylamine |
91% |
1.744uM |
1.695uM |
View
|
dopamine receptor D4 |
ASTEMIZOLE |
Dopamine D4.2 |
90% |
6.087uM |
2.134uM |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
CLOMIPHENE |
Protein Tyrosine Kinase, HER2 Receptor |
90% |
1.669uM |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
CLOMIPHENE |
Protein Tyrosine Kinase, HER2 Receptor |
90% |
1.669uM |
NoneNone |
View
|
progesterone receptor |
SPIRONOLACTONE |
Progesterone |
90% |
1.6654uM |
.2172uM |
View
|
progesterone receptor |
SPIRONOLACTONE |
Progesterone |
90% |
1.6654uM |
.2172uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
DOXAZOSIN |
Serotonin 5-HT2B |
90% |
.368uM |
.234uM |
View
|
monoamine oxidase A |
TRIOXSALEN |
Monoamine Oxidase MAOA |
90% |
.831uM |
NoneNone |
View
|
monoamine oxidase A |
TRIOXSALEN |
Monoamine Oxidase MAOA |
90% |
.831uM |
NoneNone |
View
|
thromboxane A synthase 1 |
TROGLITAZONE |
Thromboxane Synthetase |
90% |
2.966uM |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
TROGLITAZONE |
Thromboxane Synthetase |
90% |
2.966uM |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
LOPERAMIDE |
Calcium Channel Type L, Phenylalkylamine |
90% |
.589uM |
.573uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
LOPERAMIDE |
Calcium Channel Type L, Phenylalkylamine |
90% |
.589uM |
.573uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
LOPERAMIDE |
Calcium Channel Type L, Phenylalkylamine |
90% |
.589uM |
.573uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
LOPERAMIDE |
Calcium Channel Type L, Phenylalkylamine |
90% |
.589uM |
.573uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
LOPERAMIDE |
Calcium Channel Type L, Phenylalkylamine |
90% |
.589uM |
.573uM |
View
|
adenosine A2a receptor |
RWJ-68354 |
Adenosine A2A |
90% |
1.032uM |
.58uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
RWJ-68354 |
Serotonin 5-HT2C |
90% |
1.237uM |
.648uM |
View
|
Cytochrom P450-2C19 monooxygenase |
LORATADINE |
CYP450-2C19 Inhibition |
90% |
.016uM |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
gamma-aminobutyric acid A receptor, gamma 1 |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
gamma-aminobutyric acid A receptor, pi |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
AT hook, DNA binding motif, containing 1 (DBSS) |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
gamma-aminobutyric acid A receptor, theta |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
gamma-aminobutyric acid A receptor, delta |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
adrenergic receptor, alpha 2b |
L-744832 |
Adrenergic alpha2C |
90% |
3.136uM |
.456uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
L-744832 |
Adrenergic alpha2C |
90% |
3.136uM |
.456uM |
View
|
cholinergic receptor, muscarinic 2 |
KETOTIFEN |
Muscarinic M2 |
90% |
.838uM |
.298uM |
View
|
cholinergic receptor, muscarinic 1 |
SERTRALINE |
Muscarinic M1 |
90% |
1.2882uM |
.3102uM |
View
|
adrenergic receptor, beta 2 |
EPINEPHRINE |
Adrenergic beta2 |
90% |
.284uM |
.196uM |
View
|
adrenergic receptor, alpha 1d (Non-specific probe) |
NORTRIPTYLINE |
Adrenergic alpha1D |
90% |
.273uM |
.134uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
OXICONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.4711uM |
.9457uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
OXICONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.4711uM |
.9457uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
OXICONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.4711uM |
.9457uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
OXICONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.4711uM |
.9457uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
OXICONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.4711uM |
.9457uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
OXICONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.4711uM |
.9457uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
OXICONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.4711uM |
.9457uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
OXICONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.4711uM |
.9457uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
OXICONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.4711uM |
.9457uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
OXICONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.4711uM |
.9457uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
5-hydroxytryptamine receptor 6 |
YOHIMBINE |
Serotonin 5-HT6 |
91% |
1.689uM |
.784uM |
View
|
opioid receptor, sigma 1 |
CISAPRIDE |
Sigma1 |
91% |
.994uM |
.418uM |
View
|
adrenergic receptor, alpha 2a |
CLOMIPRAMINE |
Adrenergic alpha2A |
91% |
1.414uM |
.53uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
CLOZAPINE |
Calcium Channel Type L, Phenylalkylamine |
91% |
.612uM |
.595uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
CLOZAPINE |
Calcium Channel Type L, Phenylalkylamine |
91% |
.612uM |
.595uM |
View
|
interleukin 8 receptor, alpha |
MC 258717 |
Chemokine CXCR1(IL-8A) |
16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
CLOZAPINE |
Calcium Channel Type L, Phenylalkylamine |
91% |
.612uM |
.595uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
CLOZAPINE |
Calcium Channel Type L, Phenylalkylamine |
91% |
.612uM |
.595uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
CLOZAPINE |
Calcium Channel Type L, Phenylalkylamine |
91% |
.612uM |
.595uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
CLOZAPINE |
Calcium Channel Type L, Phenylalkylamine |
91% |
.612uM |
.595uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
CLOZAPINE |
Calcium Channel Type L, Phenylalkylamine |
91% |
.612uM |
.595uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
CLOZAPINE |
Calcium Channel Type L, Phenylalkylamine |
91% |
.612uM |
.595uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
CLOZAPINE |
Calcium Channel Type L, Phenylalkylamine |
91% |
.612uM |
.595uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
PROPAFENONE |
Calcium Channel Type L, Phenylalkylamine |
91% |
1.744uM |
1.695uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
PROPAFENONE |
Calcium Channel Type L, Phenylalkylamine |
91% |
1.744uM |
1.695uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
PROPAFENONE |
Calcium Channel Type L, Phenylalkylamine |
91% |
1.744uM |
1.695uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
PROPAFENONE |
Calcium Channel Type L, Phenylalkylamine |
91% |
1.744uM |
1.695uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
PROPAFENONE |
Calcium Channel Type L, Phenylalkylamine |
91% |
1.744uM |
1.695uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
PROPAFENONE |
Calcium Channel Type L, Phenylalkylamine |
91% |
1.744uM |
1.695uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
PROPAFENONE |
Calcium Channel Type L, Phenylalkylamine |
91% |
1.744uM |
1.695uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|